Percentage low-density lipoprotein cholesterol achievement goals by selected factors
| Selected factors | No | Percentage achievement | p Value |
| Sex | 0.029 | ||
| Male | 417 | 55.4 | |
| Female | 823 | 48.9 | |
| Male by age (years) at risk | 0.750 | ||
| ≥45 | 394 | 55.6 | |
| <45 | 23 | 52.2 | |
| Female by age (years) at risk | 0.057 | ||
| ≥55 of age | 623 | 50.7 | |
| <55 | 200 | 43.0 | |
| Duration (months) of statin treatment | 0.997 | ||
| 3–6 | 136 | 50.7 | |
| 7–12 | 245 | 51.0 | |
| 13–24 | 349 | 50.4 | |
| 25–36 | 235 | 51.9 | |
| ≥37 | 275 | 51.3 | |
| Statins received | 0.842 | ||
| Statins only | 1156 | 51.1 | |
| Statins with other lipid-lowering drugs | 84 | 50.0 | |
| Field of expertise of attending physicians | 0.360 | ||
| Internal medicine | 1227 | 51.2 | |
| Non-internal medicine | 13 | 38.5 | |
| Field of expertise of attending physicians who were in internal medicine | 0.598 | ||
| General | 1029 | 51.2 | |
| Cardiologist | 128 | 53.9 | |
| Endocrinologist, nephrologists or neurologist | 67 | 46.3 |